Skip to main content
Equibles
CHE logo

CHE · Chemed Corp · Metrics

Track CHE — free

Use CHE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CHE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$507.50 +4.60 (+0.91%) At close · Oct 2
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$6.70B
Shares
13.07M
Volume · Oct 2 159.12K Avg daily vol (3M) 160.72K

CHE metrics

85 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$507.50
Market cap
$6.70B

Price action

20 metrics
Price change (1W)
+1.5%
Price change (30D)
-4.0%
Price change (3M)
+2.7%
Price change (6M)
+32.1%
Price change (YTD)
+17.5%
Price change (1Y)
+14.1%
Trailing year
Price change (5Y)
+9.8%
52-week high
$552.72
52-week low
$368.59
Change from 52-week high
-9.0%
Change from 52-week low
+36.4%
Annualized volatility
29.1%
Annualized volatility (3M)
21.7%
Beta
0.0
RSI (14D)
42.4
Price vs SMA 50
-3.9%
Price vs SMA 200
+10.6%
Avg volume (3M)
160,953
Relative volume
1.3
Average dollar volume
$83.21M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
13.07M

Valuation

12 metrics
P / E (TTM)
25.3
Trailing earnings · reciprocal yield 4.0%
PEG ratio
0.6
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.6×
reciprocal yield 38.7%
P / book
8.1
reciprocal yield 12.4%
FCF yield
4.8%
TTM · current market cap
Buyback yield
9.6%
P / FCF
20.7
reciprocal yield 4.8%
P / operating cash flow
17.2
reciprocal yield 5.8%
Earnings yield
4.1%

Historical valuation

8 metrics
P / E historical average (3Y)
27.4×
reciprocal yield 3.6%
P / E historical average (5Y)
28.5×
reciprocal yield 3.5%
EV / revenue historical average (3Y)
3.7×
reciprocal yield 27.3%
EV / revenue historical average (5Y)
3.7×
reciprocal yield 27.1%
EV / EBIT historical average (3Y)
23.7×
reciprocal yield 4.2%
EV / EBIT historical average (5Y)
24.3×
reciprocal yield 4.1%
EV / EBITDA historical average (3Y)
20.0×
reciprocal yield 5.0%
EV / EBITDA historical average (5Y)
20.3×
reciprocal yield 4.9%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
12.1%
Shareholder yield
10.1%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
33.1%
Operating margin
13.5%
Trailing 12 months
Net margin
10.6%
Gross profit (TTM)
—
Operating profit (TTM)
$349.19M
Net income (TTM)
$274.99M
Trailing 12 months
Diluted EPS (TTM)
$19.88
FCF margin
12.5%
Effective tax rate
25.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$63.54

Growth

11 metrics
Revenue growth YoY
+8.8%
Year over year
Net income growth YoY
+29.0%
Revenue (TTM)
$2.60B
Trailing 12 months
EPS growth YoY
+43.7%
Shares change YoY
-10.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+5.8%
Revenue CAGR (5Y)
+4.0%
EPS CAGR (3Y)
+3.5%
EPS CAGR (5Y)
-1.2%
FCF CAGR (3Y)
+8.8%
FCF CAGR (5Y)
-5.4%

Quality

14 metrics
Return on equity
33.1%
Return on assets
17.4%
Debt / equity
—
Current ratio
0.9
EBITDA (TTM)
$415.61M
Free cash flow (TTM)
$323.61M
Quick ratio
0.9
Interest coverage
106.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$40.22M
Total assets
$1.58B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$389.95M
Capital expenditures (TTM)
$66.34M
R&D (TTM)
—
SG&A (TTM)
$440.80M
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
536
13F filer change QoQ
+43
Institutional ownership
103.9%

Short interest

3 metrics
Short interest
5.0%
Latest settlement · 5.4 days to cover
Days to cover
5.4d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.83M
Insider-sentiment score
18 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 19584 CUSIP 16359R103 13F (30d) 14 filings 10 filers Visit website Investor relations